ABT-202

ABT-202

ABT-202
Systematic (IUPAC) name
(3S)-1-(pyridin-3-yl)pyrrolidin-3-amine
Clinical data
Legal status
?
Identifiers
ATC code ?
PubChem
ChemSpider  YesY
Chemical data
Formula C9H13N3 
Mol. mass 163.219
 YesY   

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2]

References

  1. ^ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000) 5 (1): 76–81.  
  2. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767.